Insiders · PVLA

Stephen S. Yoder

Officer, Director at Pieris Pharmaceuticals, Inc. (PVLA)

Stephen S. Yoder has filed 3 insider reports with the SEC since March 2021, as officer and director at Pieris Pharmaceuticals, Inc. (PVLA). The latest filing, on February 28, 2023, reports grant or award at Pieris Pharmaceuticals, Inc. (PVLA).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Stephen S. Yoder is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pieris Pharmaceuticals, Inc. logo
PVLA
Pieris Pharmaceuticals, Inc.
Officer, Director$144.35Feb 28, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Stephen S. Yoder with

Other insiders at the same companies

Questions about Stephen S. Yoder

What is Stephen S. Yoder's role at Pieris Pharmaceuticals, Inc.?
Stephen S. Yoder reports to the SEC as officer and director at Pieris Pharmaceuticals, Inc. (PVLA), according to the latest filing on February 28, 2023.
Has Stephen S. Yoder bought or sold stock recently?
No open-market purchases or sales by Stephen S. Yoder are on file. The filings report grant or award.
How do I get alerts when Stephen S. Yoder files?
Follow Stephen S. Yoder on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Stephen S. Yoder (SEC CIK 0001645577). Totals count each trade once, skipping amendments whose original is on file, from Mar 8, 2021 on. View on SEC EDGAR